|Ask||3.7000 x 2000|
|Day's Range||3.1899 - 3.2000|
|52 Week Range||2.1600 - 4.0400|
|PE Ratio (TTM)||-0.58|
|Dividend & Yield||0.00 (0.00%)|
|1y Target Est||N/A|
The following is a list of clinical development news from private and public companies during the week of May 8-12.
Categories: Yahoo Finance Get free summary analysis Elbit Imaging Ltd. reports financial results for the quarter ended September 30, 2016. Highlights Summary numbers: Revenues of USD 16.00 million, Net Earnings of USD -6.39 million. Gross margins narrowed from 39.41% to 26.57% compared to the same period last year, operating (EBITDA) margins now -73.33% from 35.87%. Narrowing of operating ... Read more (Read more...)
Elbit Imaging Ltd. (NASDAQ: EMITF ) revealed that today that it was informed by INSIGHTEC Ltd. that the FDA has given its approval for its Exablate Neuro system for a non-invasive treatment of essential ...